Tesla stock rises on optimism over the electric-vehicle maker’s growth projections, Microsoft’s Azure growth misses estimates ...

Asian shares mostly rose Thursday after the U.S. Federal Reserve opted not to cut interest rates for the first time since it ...

Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...

As Silicon Valley entrepreneur Peter Thiel once wrote, "Competition is for losers." When a firm enjoys little competition, it ...

Esports revenue includes media rights, ticket sales, sponsorship and advertising deals, but the entire gaming industry ...

Wall Street opens up on relief Meta and Microsoft kept their AI spending plans even as their earnings come in mixed. Next up, Apple after the close.

Key tech stocks were a mixed bag in early trading Thursday after executives at Meta and Microsoft said they plan to keep ...

While RFK Jr. is likely to lead the Department of HHS, he will be limited in his ability to stop the continued innovation and ...

Earlier this week, many technology stocks sold off sharply on news of DeepSeek R1, the groundbreaking, low-cost AI model from ...

U.S. stocks were erasing early gains in recent trading, with the S&P 500 joining the Nasdaq Composite in the red. As investors responded to the latest earnings and economic reports, Nvidia Corp. has ...

DeepSeek spooked US markets on news that the model’s developers were able to produce a worthy competitor to American AI firms ...

Cardinal Health had $210 billion in pharmaceutical and specialty drugs sales in fiscal 2024, up 11% year-over-year, helped in large part by GLP-1 sales. In Q4, segment sales rose 13% to $55 billion, ...